Regulated expression of telomerase activity in human T lymphocyte development and activation

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2471-2479

  Weng, Nan Ping ^a   Levine, Bruce L ^b   June, Carl H ^b   Hodes, Richard J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A;

ARTICLE; CELL MATURATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT; IONOMYCIN; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TELOMERASE; TETRADECANOYLPHORBOL ACETATE; THYMUS GLAND; TONSIL;

EID: 0029894199     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2471     Document Type: Article

References (48)

1. Blackburn, E.H. 1991. Structure and function of telomeres. Nature (Lond.). 350:569-573.
2. Greider, C.W. 1994. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr. Opin. Genet. Dev. 4:203-211.
3. Harley, C.B., and B. Villeponteau. 1995. Telomeres and telomerase in aging and cancer. Curr. Opin. Genet. Dev. 5:249-255.
4. Zakian, V.A. 1995. Telomeres: beginning to understand the end. Science (Wash. DC). 270:1601-1607.
5. Cooke, H.J., and B.A. Smith. 1986. Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb. Symp. Quant. Biol. 51:213-219.
6. Harley, C.B., A.B. Futcher, and C.W. Greider. 1990. Telomeres shorten during ageing of human fibroblasts. Nature (Lond.). 345:458-460.
7. Hastie, N.D., M. Dempster, M.G. Dunlop, A.M. Thompson, D.K. Green, and R.C. Allshire. 1990. Telomere reduction in human colorectal carcinoma and with aging. Nature (Lond.). 346:866-868.
8. Allsopp, R.C., H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, A.B. Futcher, C.W. Greider, and C.B. Harley. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:10114-10118.
9. Vaziri, H., F. Schachter, I. Uchida, L. Wei, X. Zhu, R. Effros, D. Cohen, and C.B. Harley. 1993. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:661-667.
10. Slagboom, P.E., S. Droog, and D.I. Boomsma. 1994. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 55:876-882.
11. Vaziri, H., W. Dragowska, R.C. Allsopp, T.E. Thomas, C.B. Harley, and P.M. Lansdorp. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA. 91:9857-9860.
12. Chang, E., and C.B. Harley. 1995. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA. 92:11190-11194.
13. Weng, N., B.L. Levine, C.H. June, and R.J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA. 92:11091-11094.
14. Allsopp, R.C., and C.B. Harley. 1995. Evidence for a critical telomere length in senescent human fibroblasts. Exp. Cell Res. 219:130-136.
15. Olovnikov, A.M. 1973. A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41:181-190.
16. Lingner, J., J.P. Cooper, and T.R. Cech. 1995. Telomerase and DNA end replication: no longer a lagging strand problem? Science (Wash. DC). 269:1533-1534.
17. Blackburn, E.H. 1992. Telomerases. Annu. Rev. Biochem. 61: 113-129.
18. de Lange, T. 1994. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA. 91:2882-2885.
19. Shay, J.W. 1995. Aging and cancer: are telomeres and telomerase the connection? Mol. Med. Today. 1:378-384.
20. Kim, N.W., M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC). 266:2011-2015.
21. Counter, C.M., J. Gupta, C.B. Harley, B. Leber, and S. Bacchetti. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:2315-2320.
22. Broccoli, D., J.W. Young, and T. de Lange. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA. 92:9082-9086.
23. Hiyama, K., Y. Hirai, S. Kyoizumi, M. Akiyama, E. Hiyama, M.A. Piatyszek, J.W. Shay, S. Ishioka, and M. Yamakido. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711-3715.
24. Scollay, R. 1991. T-cell subset relationships in thymocyte development. Curr. Opin. Immunol. 3:204-209.
25. Von Boehmer, H. 1992. T cell development and selection in the thymus. Bone Marrow Transplant. 9(Suppl. 1):46-48.
26. Robey, E., and B.J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675-705.
27. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
28. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
29. Robey, E., and J.P. Allison. 1995. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol. Today. 16:306-310.
30. Horgan, K., and S. Shaw. 1994. Immunomagnetic purification of T cell subpopulations. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons, Inc., New York. 7.4.1-7.4.6.
31. June, C.H., J.A. Ledbetter, M.M. Gillespie, T. Lindsten, and C.B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7:4472-4481.
32. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:891-904.
33. Greider, C.W., and E.H. Blackburn. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:405-413.
34. Yamada, M. 1976. Method for synchronizing cells. In Tissue Culture. J. Nakai, et. al. editors. Asakura Shoten Co. Inc., Tokyo. p. 80.
35. 5 (3). In Methods in Cell Biology: Flow Cytometry. Z. Darzynkiewicz and H.A. Crissman, editors. Academic Press, London. 89-95.
36. Uehara, Y., and H. Fukazawa. 1991. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:370-379.
37. Graber, M., C.H. June, L.E. Samelson, and A. Weiss. 1992. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor. Int. Immunol. 4:1201-1210.
38. Mahon, T.M., and L.A.J. O'Neill. 1995. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappaB activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J. Biol. Chem. 270:28557-28564.
39. Kumagai, N., S.H. Benedict, G.B. Mills, and E.W. Gelfand. 1988. Cyclosporin A inhibits initiation but not progression of human T cell proliferation triggered by phorbol esters and calcium ionophores. J. Immunol. 141:3747-3752.
40. Liu, J., J.D. Farmer, Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:807-815.
41. Szamel, M., F. Bartels, and K. Resch. 1993. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta. Eur. J. Immunol. 23:3072-3081.
42. Jenkins, M.K., P.S. Taylor, S.D. Norton, and K.B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461-2466.
43. Van Gool, S.W., M. de Boer, and J.L. Ceuppens. 1993. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 150:3254-3263.
44. Truneh, A., F. Albert, P. Golstein, and A.M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (Lond.). 313:318-320.
45. Feng, J., W.D. Funk, S.S. Wang, S.L. Weinrich, A.A. Avilion, C.P. Chiu, R.R. Adams, E. Chang, R.C. Allsopp, and J. Yu. 1995. The RNA component of human telomerase. Science (Wash. DC). 269:1236-1241.
46. Blasco, M.A., W. Funk, B. Villeponteau, and C.W. Greider. 1995. Functional characterization and developmental regulation of mouse telomerase RNA. Science (Wash. DC). 269: 1267-1270.
47. Mantell, L.L., and C.W. Greider. 1994. Telomerase activity in germline and embryonic cells of Xenopus. EMBO (Eur. Mol. Biol. Organ.) J. 13:3211-3217.
48. Zeng, X., H. Hao, Y. Jiang, and M.Y.W.T. Lee. 1994. Regulation of human DNA polymerase delta during the cell cycle. J. Biol. Chem. 269:24027-24033.